BETA-ADRENOCEPTORS OF HUMAN RED BLOOD-CELLS, DETERMINATION OF THEIR SUBTYPES

被引:27
作者
BREE, F
GAULT, I
DATHIS, P
TILLEMENT, JP
机构
关键词
D O I
10.1016/0006-2952(84)90019-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The characteristics of .beta.-adrenergic receptors of human erythrocyte membrane were investigated using (-)125iodocyanopindol as a radioligand. Inhibition of (-)125iodocyanopindolol specific binding was checked using either atenolol and metoprolol as .beta.1-selective antagonists or ICI 118551 [erythro-DL-1-(7-methylindcin-4-yloxy)-3-isopropylamino-butan-2-ol] and IPS 339 [(tert-butyl-amino-3-ol-2-propyl)oximino-9 fluorene] as .beta.2-selective antagonists. The results showed nonlinear Hofstee''s plots suggesting that both .beta.1- and .beta.2-adrenergic receptor are present. Analysis of data yielded a .beta.1/.beta.2 adrenergic receptor ratio of approximately 33/67. The .beta.2-subtype is evidently predominant on human erythrocyte membranes.
引用
收藏
页码:4045 / 4050
页数:6
相关论文
共 34 条
[1]  
ARIENS EJ, 1976, RECEPTORS RECEPTOR M, P3
[2]  
BILEZIKIAN J P, 1973, Journal of Biological Chemistry, V248, P5577
[3]  
BILSKI A, 1980, BRIT J PHARMACOL, V69, pP292
[4]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[5]  
DELEAN A, 1982, MOL PHARMACOL, V21, P5
[6]  
DICKINSON K, 1981, MOL PHARMACOL, V19, P194
[7]  
DICKINSON KEJ, 1981, EUR J PHARMACOL, V94, P43
[8]  
Furchgott R.F., 1972, HDB EXPT PHARM CATEC, V33, P283
[9]  
GALANT SP, 1978, J LAB CLIN MED, V92, P613
[10]  
HEDBERG A, 1980, J PHARMACOL EXP THER, V212, P503